III Capital Management - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 27 filers reported holding EFFECTOR THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
III Capital Management ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,513
-37.8%
41,7950.0%0.00%
Q2 2023$7,251
+74.6%
41,7950.0%0.00%
Q1 2023$4,154
+3.8%
41,7950.0%0.00%
Q4 2022$4,000
-42.9%
41,7950.0%0.00%
-100.0%
Q3 2022$7,000
-22.2%
41,7950.0%0.00%0.0%
Q2 2022$9,000
-43.8%
41,7950.0%0.00%0.0%
Q1 2022$16,000
-30.4%
41,795
+61.4%
0.00%
-50.0%
Q4 2021$23,000
-11.5%
25,900
+56.9%
0.00%0.0%
Q3 2021$26,00016,5040.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 145,941$18,8560.00%
ARISTEIA CAPITAL, L.L.C. 1,540,297$153,1060.00%
Sea Otter Advisors LLC 25,000$3,2300.00%
LITTLEJOHN & CO LLC 16,666$2,1530.00%
WHITEBOX ADVISORS LLC 298,145$38,5200.00%
Citadel Advisors 27,743$3,5840.00%
III Capital Management 41,795$4,1540.00%
Tower Research Capital LLC (TRC) 23$00.00%
Parallel Advisors, LLC 64,166$4,8120.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders